95% CI: 6522416)
A meta-analysis of 77 RCTs involving 50,820 patients with T2DM found that compared with placebo, lifestyle modification, or active anti-diabetic drugs, SGLT2is were associated with a significantly higher risk of genital infections (RR, 3.30
This matters for the cost landscape because small-molecule drugs are inherently less expensive to produce at scale than biologic peptides
Apr 6, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 1,301 views GLP-1 dose escalation is quickly becoming a central topic in diabetes care, especially as higher dosing strategies gain traction
Everything stays in your canvas
Its a question we get all the time, and the distinction is crucial